|Bid||178.00 x 900|
|Ask||0.00 x 1100|
|Day's Range||189.67 - 193.38|
|52 Week Range||163.47 - 214.48|
|Beta (5Y Monthly)||0.65|
|PE Ratio (TTM)||44.05|
|Earnings Date||Apr. 01, 2020 - Apr. 05, 2020|
|Forward Dividend & Yield||3.00 (1.58%)|
|Ex-Dividend Date||Feb. 08, 2020|
|1y Target Est||225.00|
Coca-Cola (KO) launches Powerade Ultra and Powerade Power Water under Powerade Sports drink category. This is likely to aid the company's sales.
Philip Morris' (PM) performance is bearing adverse impacts of declining cigarette sales volume. However, expansion in RRPs and strong pricing are significant upsides.
Beer, wine and spirit giants and small startups alike are betting on cannabis beverages disrupting the drinks market with products that can soothe sore muscles after a workout, or deliver a hangover-free buzz.
PepsiCo (PEP) is benefiting from its growing snacks business for a while now. It is also strengthening the Frito-Lay North American with flavorful products.
First Round of Select Dates on Sale January 24 CHICAGO, Jan. 15, 2020 -- Corona Light, the number one light beer import, will be the lead sponsor behind the summer.
Beverage giants have stumbled upon a promising range of hard seltzers, satisfying their need for product diversification as well as meeting consumer preferences.
Constellation Brands (STZ) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Monster Beverage's (MNST) momentum in the energy drinks category should continue to drive performance. Also, its efforts to innovate and launch products are encouraging.
Boston Beer's (SAM) investments in the Truly brand are likely to bolster its position in the fast-growing hard seltzer category. However, costs and margin woes are clouding its growth potential.
Constellation Brands, Inc. (NYSE:STZ) investors will be delighted, with the company turning in some strong numbers...
Horizons Marijuana Life Sciences ETF (TSX:HMMJ) stock could be the ultimate proxy for a rebound in the legal pot sector.
Canopy Growth Inc (TSX:WEED)(NYSE:CGC) stock's poor price performance in Canada weighs down the high earnings at Constellation Brands (NYSE:STZ).
Discover why Hexo Corp (TSX:HEXO)(NYSE:HEXO) stock gives you more upside and less risk when compared to competitors like Canopy Growth Corp (TSX:WEED)(NYSE:CGC).
(Bloomberg) -- Constellation Brands Inc. rose the most in six months after posting profit and sales last quarter that topped analysts’ estimates and raising its full year earnings forecast.Comparable earnings of $2.14 a share in the third quarter was well above the $1.84 average of estimates, amid growth from its beer brands Modelo Especial and Corona. Comparable profit for the full year will be $9.45 to $9.55 a share, up from a previous forecast for as much as $9.20.Key InsightsConstellation has been leaning heavily on its beer business, where it’s aggressively advertising the Modelo Mexican import brand to boost sales. The brewer also is creating new items under the Corona brand in the popular hard seltzer category, with a 90-calorie drink planned to launch this year.Executives said Wednesday that they are actively looking to divest more wine and spirits brands, which have lagged behind the growth at Modelo and Corona. The company has already sold parts of the unit to E. & J. Gallo Winery and said on a conference call that Gallo will buy its New Zealand wine label Nobilo, with the deal closing next fiscal year.Constellation has also been working on reshaping its portfolio by buying a stake in the world’s most valuable cannabis company, Canopy Growth Corp. and selling Ballast Point, a craft beer it bought for about $1 billion just four years ago.Since investing in Canopy, Constellation Chief Executive Officer Bill Newlands has said he’s not happy with its performance. On Wednesday, the company said it recognized a $534 million decrease in the fair value of the investment in the third quarter. In December, Canopy named Constellation executive David Klein as CEO, raising the odds that the beer maker will buy Canopy outright.Market ReactionConstellation shares rose as much as 4.3% to $191.50 in New York Wednesday, the biggest intraday gain since June. The stock gained 18% last year, trailing the S&P 500 Index.For the company release, click here.(Adds intention to divest more wine and spirits labels in second bullet point.)To contact the reporter on this story: Leslie Patton in Chicago at email@example.comTo contact the editors responsible for this story: Sally Bakewell at firstname.lastname@example.org, Lisa Wolfson, Jonathan RoederFor more articles like this, please visit us at bloomberg.com©2020 Bloomberg L.P.
Constellation Brands reported a US$534 million decline in the value of its stake in Canopy Growth as the beer and wine giant reported fiscal third quarter results on Wednesday.
Constellation Brands' (STZ) top and bottom lines beat estimates in third-quarter fiscal 2020 on strength in the beer business and improved margins. It raises earnings and cash flow guidance.
Constellation Brands (STZ) delivered earnings and revenue surprises of 16.30% and 2.29%, respectively, for the quarter ended November 2019. Do the numbers hold clues to what lies ahead for the stock?
The brewer has been bolstering its beer portfolio through launches of variants such as Modelo Chelada Limon y Sal and Corona Refresca to woo consumers switching to trendier alternatives such as Boston Beer's Truly and White Claw hard seltzers from high-calorie beers and spirits. Constellation plans to add a hard seltzer to its Corona portfolio this year, looking to tap into the surging popularity of the alcoholic carbonated drink among millennials.
NEW YORK, NY / ACCESSWIRE / January 8, 2020 / Constellation Brands, Inc. (NYSE:STZ) will be discussing their earnings results in their 2020 Third Quarter Earnings to be held on January 8, 2020 at 10:30 ...